Detalhe da pesquisa
1.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636444
2.
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Br J Cancer
; 126(3): 449-455, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811502
3.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253871
4.
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Support Care Cancer
; 29(7): 3971-3980, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392769
5.
The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors.
Dig Liver Dis
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38772790
6.
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593068
7.
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277193
8.
Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors.
Eur J Cancer
; 187: 15-24, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099945
9.
Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV.
Eur J Cancer
; 195: 113396, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924647
10.
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors.
Clin Cancer Res
; 29(18): 3771-3778, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439810
11.
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma.
Eur J Cancer
; 194: 113354, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827067
12.
Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?
Crit Rev Oncol Hematol
; 169: 103532, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800655
13.
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy.
JCO Precis Oncol
; 6: e2200037, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544729
14.
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer.
Eur J Cancer
; 172: 171-181, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777274
15.
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.
JCO Precis Oncol
; 6: e2200015, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476549
16.
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Nat Med
; 28(8): 1612-1618, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35915157
17.
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110358
18.
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34127544
19.
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
Clin Colorectal Cancer
; 20(4): 314-317, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34364814
20.
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors.
Eur J Cancer
; 150: 155-167, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901794